Alterations of cellular bioenergetics in pulmonary artery endothelial cells

Idiopathic pulmonary arterial hypertension (IPAH) is pathogenetically related to low levels of the vasodilator nitric oxide (NO). Because NO regulates cellular respiration and mitochondrial biogenesis, we hypothesized that abnormalities of bioenergetics may be present in IPAH. Evaluation of pulmonary artery endothelial cells from IPAH and control lungs in vitro revealed that oxygen consumption of IPAH cells was decreased, especially in state 3 respiration with substrates glutamate-malate or succinate, and this decrease paralleled reduction in Complex IV activity and IPAH cellular NO synthesis. IPAH pulmonary artery endothelial cells had decreased mitochondrial dehydrogenase activity and lowered mitochondrial numbers per cell and mitochondrial DNA content, all of which increased after exposure to NO donors. Although IPAH/pulmonary artery endothelial cells' ATP content was similar to control under normoxia, cellular ATP did not change significantly in IPAH cells under hypoxia, whereas ATP decreased 35% in control cells, identifying a greater dependence on cellular respiration for energy in control cells. Evidence that glucose metabolism was subserving the primary role for energy requirements of IPAH cells was provided by the ≈3-fold greater glycolytic rate of IPAH cells. Positron emission tomography scan with [18F]fluoro-deoxy-d-glucose performed on IPAH patients and healthy controls revealed significantly higher uptake in IPAH lungs as compared with controls, confirming that the glycolytic rate was increased in vivo. Thus, there are substantial changes in bioenergetics of IPAH endothelial cells, which may have consequences for pulmonary hypertensive responses and potentially in development of novel imaging modalities for diagnosis and evaluation of treatment.

[1]  B. van Ginneken,et al.  Chest , 2009, Indian Journal of Radiology and Imaging.

[2]  E. Clementi,et al.  TNF-alpha downregulates eNOS expression and mitochondrial biogenesis in fat and muscle of obese rodents. , 2006, The Journal of clinical investigation.

[3]  Oksana Gavrilova,et al.  p53 Regulates Mitochondrial Respiration , 2006, Science.

[4]  S. Archer,et al.  An Abnormal Mitochondrial–Hypoxia Inducible Factor-1&agr;–Kv Channel Pathway Disrupts Oxygen Sensing and Triggers Pulmonary Arterial Hypertension in Fawn Hooded Rats: Similarities to Human Pulmonary Arterial Hypertension , 2006, Circulation.

[5]  Ken Garber,et al.  Energy Deregulation: Licensing Tumors to Grow , 2006, Science.

[6]  S. Groshong,et al.  Pulmonary hypertension: cellular and molecular mechanisms. , 2005, Chest.

[7]  E. Clementi,et al.  Nitric oxide and mitochondrial biogenesis: a key to long-term regulation of cellular metabolism. , 2005, Comparative biochemistry and physiology. Part A, Molecular & integrative physiology.

[8]  G. Diette,et al.  Decreased exhaled nitric oxide in pulmonary arterial hypertension: response to bosentan therapy. , 2005, American journal of respiratory and critical care medicine.

[9]  S. Schreiber,et al.  Perturbational profiling of a cell-line model of tumorigenesis by using metabolic measurements , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[10]  Enrique Cadenas,et al.  On the mechanism and biology of cytochrome oxidase inhibition by nitric oxide. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[11]  E. Clementi,et al.  Mitochondrial biogenesis by NO yields functionally active mitochondria in mammals. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[12]  R. Gillies,et al.  Why do cancers have high aerobic glycolysis? , 2004, Nature Reviews Cancer.

[13]  S. Hazen,et al.  Increased arginase II and decreased NO synthesis in endothelial cells of patients with pulmonary arterial hypertension , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[14]  C. Thompson,et al.  An activated mTOR mutant supports growth factor-independent, nutrient-dependent cell survival , 2004, Oncogene.

[15]  S. Hazen,et al.  Rapid and Selective Oxygen-regulated Protein Tyrosine Denitration and Nitration in Mitochondria* , 2004, Journal of Biological Chemistry.

[16]  A. Biondi,et al.  Methods to detect mitochondrial function , 2004, Experimental Gerontology.

[17]  W. Bottje,et al.  Investigation of proton conductance in liver mitochondria of broilers with pulmonary hypertension syndrome. , 2004, Poultry science.

[18]  A. Wear.  CIRCULATION , 1964, The Lancet.

[19]  D. Schuster,et al.  Molecular imaging of enzyme function in lungs. , 2004, Methods in enzymology.

[20]  E. Clementi,et al.  Mitochondrial Biogenesis in Mammals: The Role of Endogenous Nitric Oxide , 2003, Science.

[21]  A. Ramachandran,et al.  Mitochondria, nitric oxide, and cardiovascular dysfunction. , 2002, Free radical biology & medicine.

[22]  X. Bigard,et al.  Endothelial nitric oxide synthase (NOS) deficiency affects energy metabolism pattern in murine oxidative skeletal muscle. , 2002, The Biochemical journal.

[23]  N. Morrell,et al.  Molecular and cellular basis of pulmonary vascular remodeling in pulmonary hypertension. , 2002, Progress in cardiovascular diseases.

[24]  T. Giles,et al.  Adenoviral gene transfer of endothelial nitric-oxide synthase (eNOS) partially restores normal pulmonary arterial pressure in eNOS-deficient mice , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[25]  W. Bottje,et al.  Heart and breast muscle mitochondrial dysfunction in pulmonary hypertension syndrome in broilers (Gallus domesticus). , 2002, Comparative biochemistry and physiology. Part A, Molecular & integrative physiology.

[26]  W. Wong,et al.  Positron emission tomography (PET)--evaluation of 'indeterminate pulmonary lesions'. , 2002, Clinical oncology (Royal College of Radiologists (Great Britain)).

[27]  J. Dyck,et al.  Dichloroacetate, a Metabolic Modulator, Prevents and Reverses Chronic Hypoxic Pulmonary Hypertension in Rats: Role of Increased Expression and Activity of Voltage-Gated Potassium Channels , 2002, Circulation.

[28]  马建新,et al.  用FEV6．0代替FVC诊断气道阻塞和肺功能受限[英]／Swanney MP…∥Am J Respir Crit Care Med． , 2002 .

[29]  R. Speich,et al.  Clinical classification of pulmonary hypertension. , 2004, Journal of the American College of Cardiology.

[30]  R. Wideman,et al.  Lung mitochondrial dysfunction in pulmonary hypertension syndrome. I. Site-specific defects in the electron transport chain. , 2001, Poultry science.

[31]  D. Turnbull,et al.  Assaying mitochondrial respiratory complex activity in mitochondria isolated from human cells and tissues. , 2001, Methods in cell biology.

[32]  A. Arroliga,et al.  High Levels of Nitric Oxide in Individuals with Pulmonary Hypertension Receiving Epoprostenol Therapy , 2001, Lung.

[33]  M. Ebaid,et al.  Effects of Low Doses of Inhaled Nitric Oxide Combined with Oxygen for the Evaluation of Pulmonary Vascular Reactivity in Patients with Pulmonary Hypertension , 2001, Pediatric Cardiology.

[34]  S. Rich,et al.  Primary pulmonary hypertension: a vascular biology and translational research "Work in progress". , 2000, Circulation.

[35]  S. Moncada.  Nitric oxide: discovery and impact on clinical medicine , 1999, Journal of the Royal Society of Medicine.

[36]  A. Schapira,et al.  Mitochondrial involvement in Parkinson's disease, Huntington's disease, hereditary spastic paraplegia and Friedreich's ataxia. , 1999, Biochimica et biophysica acta.

[37]  P. Huang,et al.  The pulmonary circulation of homozygous or heterozygous eNOS-null mice is hyperresponsive to mild hypoxia. , 1999, The Journal of clinical investigation.

[38]  A. Arroliga,et al.  Biochemical reaction products of nitric oxide as quantitative markers of primary pulmonary hypertension. , 1998, American journal of respiratory and critical care medicine.

[39]  J. Cooke,et al.  Derangements of the nitric oxide synthase pathway, L-arginine, and cardiovascular diseases. , 1997, Circulation.

[40]  J. Schrader,et al.  Energy turnover of vascular endothelial cells. , 1997, The American journal of physiology.

[41]  J. Remacle,et al.  Protection of hypoxia-induced ATP decrease in endothelial cells by ginkgo biloba extract and bilobalide. , 1995, Biochemical pharmacology.

[42]  A Giaid,et al.  Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension. , 1995, The New England journal of medicine.

[43]  M. Humbert,et al.  Increased interleukin-1 and interleukin-6 serum concentrations in severe primary pulmonary hypertension. , 1995, American journal of respiratory and critical care medicine.

[44]  Ahmed Me,et al.  Logistic regression for social-economic and cultural factors affecting diarrhea diseases in children under two years in Egypt. , 1994 .

[45]  B. Groves,et al.  Exuberant endothelial cell growth and elements of inflammation are present in plexiform lesions of pulmonary hypertension. , 1994, The American journal of pathology.

[46]  T. Noll,et al.  Mitochondrial function in the oxygen depleted and reoxygenated myocardial cell. , 1994, Cardiovascular research.

[47]  L. Ignarro.  Nitric Oxide-mediated Vasorelaxation , 1993, Thrombosis and Haemostasis.

[48]  S. Ogawa,et al.  Hypoxia induces glucose transporter expression in endothelial cells. , 1992, The American journal of physiology.

[49]  F. Murad,et al.  Isoforms of nitric oxide synthase. Characterization and purification from different cell types. , 1991, Biochemical pharmacology.

[50]  C. Nathan,et al.  Secretion of pyruvate. An antioxidant defense of mammalian cells , 1987, The Journal of experimental medicine.

[51]  J. Singh,et al.  Pyruvate and related alpha-ketoacids protect mammalian cells in culture against hydrogen peroxide-induced cytotoxicity. , 1985, Toxicology letters.

[52]  K. Hagino-Yamagishi,et al.  [Oncogene]. , 2019, Gan to kagaku ryoho. Cancer & chemotherapy.

[53]  F. Sanger,et al.  Sequence and organization of the human mitochondrial genome , 1981, Nature.

[54]  J. Foker,et al.  Aerobic glycolysis during lymphocyte proliferation , 1976, Nature.

[55]  S. Weinhouse.  Glycolysis, respiration, and anomalous gene expression in experimental hepatomas: G.H.A. Clowes memorial lecture. , 1972, Cancer research.

[56]  P. J. Randle,et al.  The pentose cycle and insulin release in mouse pancreatic islets. , 1972, The Biochemical journal.